TickerFactsScreenerDevelopers

Neurogene Inc. (NGNE) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $9.24M2012: $2.00M2013: $11.01M2014: $14.91M2015: $39.53M2016: $32.30M2017: $52.03M2018: $76.93M2019: $143.09M2020: $192.56M2021: $142.47M2022: $82.02M2023: $148.21M2024: $136.59M2025: $103.84M$103.84M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$103.84M-24.0%
2024$136.59M-7.8%
2023$148.21M+80.7%
2022$82.02M-42.4%
2021$142.47M-26.0%
2020$192.56M+34.6%
2019$143.09M+86.0%
2018$76.93M+47.8%
2017$52.03M+61.1%
2016$32.30M-18.3%
2015$39.53M+165.2%
2014$14.91M+35.4%
2013$11.01M+450.0%
2012$2.00M-78.3%
2011$9.24M—